Zvi Shmuel Ben

Executive

US·SEC (Form 4)

Protalix BioTherapeutics, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 04 Sept 2025 for Protalix BioTherapeutics, Inc..

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Zvi Shmuel Ben: trading record in brief

One trade, one date: on 4 September 2025, Zvi Shmuel Ben disclosed a share grant in Protalix BioTherapeutics, Inc. No broader history exists yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Zvi Shmuel Ben

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Protalix BioTherapeutics, Inc. (US)

Declarations1 total

◆

Zvi Shmuel Ben

DirectorExecutives3 Sept 2025Protalix BioTherapeutics, Inc.

0SEC

7,500 sharesCommon StockSEC:0001415889-25-023703:0

1 of 1 declaration

Zvi Shmuel Ben

Insider track record

Zvi Shmuel Ben: trading record in brief

Companies and markets linked to Zvi Shmuel Ben

Related entities

Zvi Shmuel Ben

Insider track record

Zvi Shmuel Ben: trading record in brief

Companies and markets linked to Zvi Shmuel Ben

Related entities